Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-07-23

Clinical Trial Update: Evaluation of Alcon Ladarvision Wavefront-Guided PRK [NA]

View source ↗

Summary

The clinical trial evaluating Alcon Ladarvision Wavefront-Guided PRK for myopia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alcon Ladarvision Wavefront-Guided PRK

Snippet

Sponsor: Walter Reed Army Medical Center | Conditions: Myopia | NA | Status: WITHDRAWN